| Dr Ian Savage Elliott, MD | |
|
200 W Esplanade Ave, Kenner, LA 70065-2489 | |
| (504) 464-8588 | |
| (504) 842-7530 |
| Full Name | Dr Ian Savage Elliott |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 8 Years |
| Location | 200 W Esplanade Ave, Kenner, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962853853 | NPI | - | NPPES |
| 200103371 | Medicaid | MO |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ochsner Medical Center-kenner | Kenner, LA | Hospital |
| Ochsner Clinic Foundation | New orleans, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ochsner Clinic Llc | 8224933619 | 2403 |
News Archive
Intarcia Therapeutics, Inc. today announced the presentation of results from its first two phase 3 clinical trials (FREEDOM-1 and FREEDOM-1 HBL) of its late-stage investigational candidate ITCA 650 (exenatide delivered continuously via a small matchstick-size subcutaneous osmotic mini-pump just once or twice yearly) at the 75th Scientific Sessions of the American Diabetes Association.
Democrats earned a single, coveted Republican vote for health reform legislation - from Sen. Olympia Snowe, R-Maine, - in the Senate Finance Committee, bringing them closer to the goal of bipartisan support, the Boston Globe reports
Anastomotic leakage occurs after one in 10 anterior resection procedures and costs English hospitals up to £ 3.5 milion per year, research shows.
Angiochem, a clinical stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier (BBB), today announced the initiation of a Phase 2 clinical study with ANG1005, a novel paclitaxel-peptide drug conjugate, in patients with recurrent high-grade glioma.
› Verified 7 days ago
| Entity Name | Ochsner Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
Intarcia Therapeutics, Inc. today announced the presentation of results from its first two phase 3 clinical trials (FREEDOM-1 and FREEDOM-1 HBL) of its late-stage investigational candidate ITCA 650 (exenatide delivered continuously via a small matchstick-size subcutaneous osmotic mini-pump just once or twice yearly) at the 75th Scientific Sessions of the American Diabetes Association.
Democrats earned a single, coveted Republican vote for health reform legislation - from Sen. Olympia Snowe, R-Maine, - in the Senate Finance Committee, bringing them closer to the goal of bipartisan support, the Boston Globe reports
Anastomotic leakage occurs after one in 10 anterior resection procedures and costs English hospitals up to £ 3.5 milion per year, research shows.
Angiochem, a clinical stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier (BBB), today announced the initiation of a Phase 2 clinical study with ANG1005, a novel paclitaxel-peptide drug conjugate, in patients with recurrent high-grade glioma.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ian Savage Elliott, MD 1514 Jefferson Hwy, New Orleans, LA 70121-2429 Ph: (504) 842-4000 | Dr Ian Savage Elliott, MD 200 W Esplanade Ave, Kenner, LA 70065-2489 Ph: (504) 464-8588 |
News Archive
Intarcia Therapeutics, Inc. today announced the presentation of results from its first two phase 3 clinical trials (FREEDOM-1 and FREEDOM-1 HBL) of its late-stage investigational candidate ITCA 650 (exenatide delivered continuously via a small matchstick-size subcutaneous osmotic mini-pump just once or twice yearly) at the 75th Scientific Sessions of the American Diabetes Association.
Democrats earned a single, coveted Republican vote for health reform legislation - from Sen. Olympia Snowe, R-Maine, - in the Senate Finance Committee, bringing them closer to the goal of bipartisan support, the Boston Globe reports
Anastomotic leakage occurs after one in 10 anterior resection procedures and costs English hospitals up to £ 3.5 milion per year, research shows.
Angiochem, a clinical stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier (BBB), today announced the initiation of a Phase 2 clinical study with ANG1005, a novel paclitaxel-peptide drug conjugate, in patients with recurrent high-grade glioma.
› Verified 7 days ago
Michael W Hartman, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 W Esplanade Ave, Suite 500, Kenner, LA 70065 Phone: 504-412-1700 Fax: 504-412-1701 | |
Mr. Kenneth Lawrence Veca Sr., MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3008 Palm Vista Dr, Kenner, LA 70065 Phone: 504-887-7942 Fax: 504-780-2568 | |
Vinod Dasa, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 W Esplanade Ave, Suite 500, Kenner, LA 70065 Phone: 504-412-1700 Fax: 504-412-1701 | |
Kayleigh Eppling Binet, PA-C Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 W Esplanade Ave, Kenner, LA 70065 Phone: 504-464-8588 | |
Ronald J French Jr., MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 W Esplanade Ave, Suite 210, Kenner, LA 70065 Phone: 504-464-8588 | |
George Andrew Murphy Iii, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 671 W Esplanade Ave, Suite 100, Kenner, LA 70065 Phone: 504-471-3000 | |
Howard S Hirsch, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 W Esplanade Ave, Kenner, LA 70065 Phone: 504-464-8588 |